18th Annual Indy Hematology Review

18th Annual Indy Hematology Review is organized by Indy Hematology Education (IHE), Inc. and will be held on Aug 21, 2021 at The Westin Indianapolis, Indianapolis, Indiana, United States of America. This conference also held as Virtual.

Target Audience:
The Indy Hematology Review™ brings together over 400 hematologists, oncologists, radiologists, physician assistants, oncology RN’s, nurse practitioners, pharmacists, medical students, and other allied health professionals to examine significant scientific updates in clinical hematologic research. Learn how these updates directly affect the study and practice of hematology and discover how new research can be translated into new patient care strategies.

Accreditation:
Physicians:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Designation Statement:
Purdue University College of Pharmacy designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s)™. Symposium – 8:30 am – 6:50 pm. Purdue University College of Pharmacy designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™ (Town Hall Interactive Meeting – 7 – 8:30 pm). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Accreditation Statement:
• This program is approved for 8.5 contact hours (Symposium: 8:30 am – 6:50 pm).
• This program is approved for 1.50 contact hours (Town Hall Interactive Meeting: 7 – 8:30 pm).

Description:
This annual hematology review is one of the most comprehensive, educational hematology conferences in the country. Their exceptional faculty will provide a concise and practical summary of the American Society of Hematology annual meeting, presenting the most current hematology research and clinical practice.

Objectives:
Participating in the Symposium will affect competence, performance, and patient outcomes in a variety of ways:
• Attendees will be able to implement the most clinically effective management strategies for the various types and stages of lymphoma, leukemia, and multiple myeloma to improve patient care.
• Attendees will know and understand how to apply updated research in the diagnosis and treatment
of Waldenström’s Macroglobulinemia.
• Attendees will know the new advancements in immune check point inhibitors within hematologic malignancies and use case reports and summary information to update their knowledge in hematologic malignancies.
• Attendees will have knowledge of new treatment regimens for Hematopoietic Stem Cell transplant and know when to apply relevant treatment and when to avoid.
• Attendees will know up to date research information on benign hematology.
• Attendees will be updated on new management strategies in follicular lymphoma, with updated first line, second line, and maintenance treatment options.

Additional details will be posted as soon as information is available.